Health Care M&A Weekly Deals, The Week Ending May 18, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price Webster Capital Behavior Development Group N/A The Halifax Group ChanceLight Behavioral Health, Therapy & Education N/A Fulcrum Equity Partners and Vocap Investment Partners, LLC... Read More »
Health Care M&A Weekly Deals, The Week Ending May 11, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price Periscope Equity LLC Integrated Behavioral Health N/A InTandem Capital Partners LLC Turning Point Centers N/A Biotechnology Acquirer Target Price Provention Bio, Inc. 2 clinical-stage autoimmune... Read More »
Health Care M&A Weekly Deals, The Week Ending May 4, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Spectrum Pharmaceuticals, Inc. Exclusive license to methods of use of poziotinib N/A Janssen Biotech, Inc. BeneVir Biopharm, Inc. N/A Vascugen Inc. Exclusive license to blood vessel formation technology... Read More »
April 2018 Healthcare Deals Explode
Boom! That was April 2018’s M&A results breaking the sound barrier. With 167 transactions, the monthly deal total (almost) blew away the record for deals in a single month. The current record is now January 2017, with 178 transactions. With time, as more deals come to light, April 2018 may be the new champion. Deal volume was 21% higher than the 138 transactions reported in March 2018, and up 55% compared with April 2017’s 108 transactions. The Long-Term Care sector was a major force behind the surge in deal volume. A record 46 deals were reported, representing a 92% increase over March’s anemic 24 deals, and a 130% gain over the 20 deals reported a year earlier.... Read More »
